Investor profile for Alerion Ventures: stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.
Alerion Ventures
stages, portfolio and investment profile
Charleston, South Carolina evergreen venture firm focused on early-stage B2B software and technology-enabled services across the Southeast — typically after initial traction, partnering with other institutional investors.
Keep track of Alerion Ventures
Save this profile to your VCT watchlist for a quick return.
Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.
Alerion focuses on early-stage B2B companies — typically seed and Series A after proof-of-concept traction. The firm can participate opportunistically in growth rounds but is not a late-stage growth equity shop.
Public directories cite indicative $1M–$5M ranges for Alerion deals. Founders should confirm current evergreen capacity with the partnership.
Alerion is headquartered in Charleston, SC (105 Broad Street). The firm prefers Southeast U.S. headquarters and considers national deals outside the West Coast and Northeast.
B2B software, technology-enabled services, healthcare software, and capital-efficient enterprise models. Alerion explicitly avoids consumer, drug discovery, medical devices, and project finance.
Alerion often co-invests alongside experienced venture firms. Lead vs. participant roles vary by deal — confirm with the partnership.
Public portfolio names include PhishLabs (cybersecurity, Charleston HQ before HelpSystems acquisition), Payzer, and other Southeast B2B companies per Alerion materials.
Start at alerion.ventures with B2B traction, a scalable market, and a preference for Southeast HQ or relocation. Consumer pitches are out of scope.
Both are Charleston early-stage firms. Good Growth emphasizes transformative science and technology with Boston ties; Alerion is an evergreen B2B software investor with a Southeast preference.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
